Scientific News

Scientific Posters from ECCMID 2008

8th May 2008

At this years 18th European Congress of Clinical Microbiology and Infectious Diseases, Myconostica Ltd presented 2 posters titled:Clinical performance of FXG™ : RESP (Asp +) assay for Aspergillus on respiratory specimensClinical performance of FXG™ : RESP (Asp +) assay for Pneumocystis jirovecii on ... Read More

Myconostica Ltd. announces first diagnostic products for life threatening respiratory fungal infections

29th October 2007

Products showcased at Trends In Medical Mycology 2007... Read More

Myconostica’s Founder delivers lecture at ICCC in Dubai on molecular diagnosis of invasive fungal infections.

24th April 2007

Professor Denning gave a state of the art talk about rapid diagnosis of life-threatening fungal infections in intensive care at International Critical Care Conference (ICCC) in Dubai today. Myconostica’s PneuMyco product prototype featured highly because of its high sensitivity and the difficulties in ... Read More

Myconostica’s Founder to deliver talk on Molecular Diagnosis of Fungal Infections at the 6th International Symposium on Antimicrobial Agents and Resistance in Singapore (ISAAR).

1st November 2006

Myconostica Ltd announced today that its Founder and Research Director, Professor David Denning is to give a talk on Molecular Diagnosis of Fungal Infections in Singapore on March 7 th 2007 . Hosted by the Asian-Pacific Research Foundation for Infectious Diseases (ARFID), ISAAR is the most well represented ... Read More

Myconostica’s Founder to deliver keynote talk at the New York Academy of Sciences

26th October 2006

Myconostica Ltd announced today that its Founder and Research Director, Professor David Denning is to give the opening address at a dedicated meeting of the New York Academy of Sciences... Read More